• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Breast Cancer: Combined Risk Assessment Prompts Treatment De-Escalation

0
  • by Peter Goodwin
  • in AJO · Audio · Oncology
  • — 16 Apr, 2018
Breast Cancer: Combined Risk Assessment Prompts Treatment De-Escalation
Gene Test Risk Combination Prompts Breast Treatment De-Escalation
Breast Cancer: Combined Risk Assessment Prompts Treatment De-Escalation
AudioMedica News
Breast Cancer: Combined Risk Assessment Prompts Treatment De-Escalation
Breast Cancer: Combined Risk Assessment Prompts Treatment De-Escalation
00:00 / 12 mins
Apple Podcasts Spotify Stitcher
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-3561"/>

Subscribe: Apple Podcasts | Spotify | Stitcher

BARCELONA—Not only was breast conserving therapy safer than mastectomy for most low-risk patients in the large randomized EORTC 10041/BIG 03-04 MINDACT trial reported at the 2018 European Breast Cancer Conference but also many patients could be advised to avoid chemotherapy and radiotherapy altogether after assessing their risk as “low” by using a combination of clinical and genetic risk scores, the study concluded.

Emiel Rutgers MD, PhD, a surgeon at the Netherlands Cancer Institute and professor of surgical oncology at the University of Amsterdam said MINDACT found an overall five-year loco-regional recurrence rate of only 2.1 per cent in patients treated conservatively and 2.5 per cent in those who had mastectomy. Tumor size and grade were the only independent risk factors and the results provided “the opportunity to prospectively study de-escalation of radiotherapy in women with low-risk early breast cancer”. He discussed his study and the clinical implications for the Audio Journal of Oncology.

Share

Tags: 70 gene signatureavoid radiotherapy in breast cancerbreast cancer risklow-risk breast cancerOncology

You may also like...

  • Daniel Hayes MD, Clinical Director of the Breast Oncology Program at the University of Michigan Cancer Center Ann Arbor Genetic Tests for Breast Cancer Late Recurrence Risk—Not Yet Ready for Prime Time 24 Mar, 2015
  • Oncology Times Broadcast News with the Audio Journal of Oncology – February 2009 Oncology Times Broadcast News with the Audio Journal of Oncology – February 2009 9 Feb, 2009
  • Jonathan Peled, New York Microbiome Diversity Key To Survival After Allogeneic Hematopoietic Cell Transplantation 14 Jan, 2020
  • ASCO Audio Journal of Oncology – June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6 ASCO Audio Journal of Oncology – June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6 5 Jun, 2006

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Physical Therapy Boosts Brain Power in Hemiplegic Cerebral Palsy—PEDIATRIC PHYSICAL THERAPY
  • Next story Reassurance on Ductal Carcinoma in Situ (DCIS) Treatment De-Escalation
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Brachytherapy “Excellent” After Breast…
    • Polygenic Risk Scores Could Help Predict Second…
  • Home
  • Oncology
  • AJO
  • Breast Cancer: Combined Risk Assessment Prompts Treatment De-Escalation

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.